|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Chu EA and Kim YJ: Laryngeal cancer:
diagnosis and preoperative work-up. Otolaryngol Clin North Am.
41:673–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang XB, Shen XH, Li L, Zhang YF and Chen
GQ: SOX2 overexpression correlates with poor prognosis in laryngeal
squamous cell carcinoma. Auris Nasus Larynx. 40:481–486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Airaksinen MS, Holm L and Hätinen T:
Evolution of the GDNF family ligands and receptors. Brain Behav
Evol. 68:181–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baloh RH, Tansey MG, Lampe PA, et al:
Artemin, a novel member of the GDNF ligand family, supports
peripheral and central neurons and signals through the
GFRalpha3-RET receptor complex. Neuron. 21:1291–1302. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Airaksinen MS and Saarma M: The GDNF
family: signalling, biological functions and therapeutic value. Nat
Rev Neurosci. 3:383–394. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Airaksinen MS, Titievsky A and Saarma M:
GDNF family neurotrophic factor signaling: four masters, one
servant? Mol Cell Neurosci. 13:313–325. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esseghir S, Todd SK, Hunt T, et al: A role
for glial cell derived neurotrophic factor induced expression by
inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation
in breast cancer. Cancer Res. 67:11732–11741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang J, Perry JK, Pandey V, et al: Artemin
is oncogenic for human mammary carcinoma cells. Oncogene.
28:2034–2045. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pandey V, Jung Y, Kang J, et al: Artemin
reduces sensitivity to doxorubicin and paclitaxel in endometrial
carcinoma cells through specific regulation of CD24. Transl Oncol.
3:218–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pandey V, Qian PX, Kang J, et al: Artemin
stimulates oncogenicity and invasiveness of human endometrial
carcinoma cells. Endocrinology. 151:909–920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang JZ, Kong XJ, Kang J, et al:
Artemin-stimulated progression of human non-small cell lung
carcinoma is mediated by BCL2. Mol Cancer Ther. 9:1697–1708. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ceyhan GO, Giese NA, Erkan M, et al: The
neurotrophic factor artemin promotes pancreatic cancer invasion.
Ann Surg. 244:274–281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li S, Li Z, Guo F, et al: miR-223
regulates migration and invasion by targeting Artemin in human
esophageal carcinoma. J Biomed Sci. 18:242011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu ZS, Pandey V, Wu WY, Ye S, Zhu T and
Lobie PE: Prognostic significance of the expression of GFRα1, GFRα3
and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma. BMC
Cancer. 13:342013.PubMed/NCBI
|
|
16
|
Thompson L: World Health Organization
classification of tumours: pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
17
|
Sobin L and Wittekind C: TNM
classification of malignant tumours. 6th edition. Wiley-Liss; New
York, NY: pp. 392002
|
|
18
|
Yang Q, Liu Y, Huang Y, et al: Expression
of COX-2, CD44v6 and CD147 and relationship with invasion and lymph
node metastasis in hypopharyngeal squamous cell carcinoma. PLoS
One. 8:e710482013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Masunaga R, Kohno H, Dhar DK, et al:
Cyclooxygenase-2 expression correlates with tumor
neovascularization and prognosis in human colorectal carcinoma
patients. Clin Cancer Res. 6:4064–4068. 2000.PubMed/NCBI
|
|
20
|
Banerjee A, Qian P, Wu ZS, et al: Artemin
stimulates radio- and chemo-resistance by promoting
TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary
carcinoma cells. J Biol Chem. 287:42502–42515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Banerjee A, Wu ZS, Qian P, et al: ARTEMIN
synergizes with TWIST1 to promote metastasis and poor survival
outcome in patients with ER negative mammary carcinoma. Breast
Cancer Res. 13:R1122011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banerjee A, Wu ZS, Qian PX, et al: ARTEMIN
promotes de novo angiogenesis in ER negative mammary carcinoma
through activation of TWIST1-VEGF-A signalling. PLoS One.
7:e500982012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoong LF, Wan G and Too HP: GDNF-induced
cell signaling and neurite outgrowths are differentially mediated
by GFRalpha1 isoforms. Mol Cell Neurosci. 41:464–473. 2009.
View Article : Google Scholar : PubMed/NCBI
|
